Recent research has established that the gut microbiota and its associated metabolic products are fundamental regulators of immune checkpoint blockade (ICB) efficacy in cancer treatment. These microorganisms influence therapeutic outcomes through various mechanisms, including antigenic cross-reactivity, the movement of microbes to lymph nodes, and the systemic circulation of metabolites like short...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
